Caspofungin Acetate

Caspofungin Acetate is a lipopeptide antifungal drug. It is a member of a new class of antifungals termed the echinocandins. It works by inhibiting the enzyme (1→3)-β-D-glucan synthase and thereby disturbing the integrity of the fungal cell wall. Caspofungin was the first inhibitor of fungal (1→3)-β-D-glucan synthesis to be approved by the United States Food and Drug Administration. It is administered intravenously.
It is approved by NMPA.
For this API product, US-DMF and EDMF of this API is available.  It has been exported to multiple countries in Asia, North African and South American.